- Home
- ALXO vs TORO Comparison
ALXO vs TORO Comparison
Compare ALXO & TORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALXO
- TORO
- Stock Information
- Founded
- ALXO 2015
- TORO 2022
- Country
- ALXO United States
- TORO Cyprus
- Employees
- ALXO N/A
- TORO N/A
- Industry
- ALXO Biotechnology: Pharmaceutical Preparations
- TORO Marine Transportation
- Sector
- ALXO Health Care
- TORO Consumer Discretionary
- Exchange
- ALXO Nasdaq
- TORO Nasdaq
- Market Cap
- ALXO 93.7M
- TORO 78.4M
- IPO Year
- ALXO 2020
- TORO N/A
- Fundamental
- Price
- ALXO $1.26
- TORO $3.51
- Analyst Decision
- ALXO Strong Buy
- TORO
- Analyst Count
- ALXO 6
- TORO 0
- Target Price
- ALXO $3.30
- TORO N/A
- AVG Volume (30 Days)
- ALXO 424.8K
- TORO 51.8K
- Earning Date
- ALXO 11-07-2025
- TORO 11-14-2025
- Dividend Yield
- ALXO N/A
- TORO N/A
- EPS Growth
- ALXO N/A
- TORO N/A
- EPS
- ALXO N/A
- TORO 0.01
- Revenue
- ALXO N/A
- TORO $20,143,992.00
- Revenue This Year
- ALXO N/A
- TORO N/A
- Revenue Next Year
- ALXO N/A
- TORO N/A
- P/E Ratio
- ALXO N/A
- TORO $279.87
- Revenue Growth
- ALXO N/A
- TORO 0.40
- 52 Week Low
- ALXO $0.40
- TORO $1.70
- 52 Week High
- ALXO $2.27
- TORO $4.94
- Technical
- Relative Strength Index (RSI)
- ALXO 38.76
- TORO 44.34
- Support Level
- ALXO $1.49
- TORO $3.51
- Resistance Level
- ALXO $1.64
- TORO $4.19
- Average True Range (ATR)
- ALXO 0.14
- TORO 0.14
- MACD
- ALXO -0.05
- TORO -0.10
- Stochastic Oscillator
- ALXO 4.13
- TORO 10.29
About ALXO ALX Oncology Holdings Inc.
ALX Oncology Holdings Inc is a clinical-stage immuno-oncology company focused on helping patients fight cancer by developing a pipeline of product candidates based on expertise in protein engineering and oncology led by the CD47 blocker, evorpacept, currently in phase 1 and 2 clinical trials. Cancer cells leverage CD47, a cell surface protein, as a don't eat me signal to evade detection by the immune system. The company is developing a next-generation checkpoint inhibitor designed to have a high affinity for CD47 and to avoid the limitations caused by hematologic toxicities inherent in other CD47 blocking approaches.
About TORO Toro Corp.
Toro Corp acquires, owns, charters, and operates oceangoing tanker vessels and provides seaborne transportation services for crude oil and refined petroleum products. It operates in three reportable segments: the Aframax tanker, the LPG carrier segment, and the Handysize tanker. The company generates maximum revenue from the Aframax tanker segment.